OptimizeRx Corp (OPRX) › Operating IncomeOptimizeRx Corp (OPRX) — Operating IncomeAnnual figures by period end, from SEC filings.2010-12-31: -$1.85M2011-12-31: -$1.45M2012-12-31: -$454.9K2013-12-31: -$267.5K2014-12-31: -$1.03M2015-12-31: -$597.4K2016-12-31: -$1.58M2017-12-31: -$2.13M2018-12-31: $180.1K2019-12-31: -$3.69M2020-12-31: -$2.14M2021-12-31: $361.1K2022-12-31: -$12.29M2023-12-31: -$26.40M2024-12-31: -$13.71M2025-12-31: $11.69M$11.69M2010-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31$11.69M—2026-03-12From 2025-01-012024-12-31-$13.71M—2026-03-12From 2024-01-012023-12-31-$26.40M—2025-03-20From 2023-01-012022-12-31-$12.29M-3503.7%2024-04-15From 2022-01-012021-12-31$361.1K—2023-03-10From 2021-01-012020-12-31-$2.14M—2023-03-10From 2020-01-012019-12-31-$3.69M-2150.5%2021-03-08From 2019-01-012018-12-31$180.1K—2020-03-26From 2018-01-012017-12-31-$2.13M—2019-03-12From 2017-01-012016-12-31-$1.58M—2018-03-08From 2016-01-012015-12-31-$597.4K—2017-03-08From 2015-01-012014-12-31-$1.03M—2016-03-15From 2014-01-012013-12-31-$267.5K—2015-09-16From 2013-01-012012-12-31-$454.9K—2014-03-31From 2012-01-012011-12-31-$1.45M—2012-03-30From 2011-01-012010-12-31-$1.85M—2012-03-30From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)